{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:51:37Z","timestamp":1791726697611,"version":"4.3.4"},"publisher-location":"New York, NY","reference-count":151,"publisher":"Springer US","isbn-type":[{"value":"9781071606391","type":"print"},{"value":"9781071606407","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0640-7_1","type":"book-chapter","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T16:49:27Z","timestamp":1591807767000},"page":"3-25","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease"],"prefix":"10.1007","author":[{"given":"Saverio Francesco","family":"Retta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Perrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Trabalzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Finetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,11]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","unstructured":"Rigamonti D (2011) Cavernous malformations of the nervous system. Cambridge University Press, Cambridge,\u00a0United Kingdom","DOI":"10.1017\/CBO9781139003636"},{"key":"1_CR2","unstructured":"Fontanella M (2015) Cerebral cavernous malformations (CCM). Minerva Medica, Torino, Italy"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11886-017-0931-1","volume":"19","author":"KD Flemming","year":"2017","unstructured":"Flemming KD (2017) Clinical management of cavernous malformations. Curr Cardiol Rep 19:122","journal-title":"Curr Cardiol Rep"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1093\/hmg\/10.25.2953","volume":"10","author":"J Zhang","year":"2001","unstructured":"Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC (2001) Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953\u20132960","journal-title":"Hum Mol Genet"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.clineuro.2012.06.023","volume":"115","author":"G Tanriover","year":"2013","unstructured":"Tanriover G, Sozen B, Seker A, Kilic T, Gunel M, Demir N (2013) Ultrastructural analysis of vascular features in cerebral cavernous malformations. Clin Neurol Neurosurg 115:438\u2013444","journal-title":"Clin Neurol Neurosurg"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3174\/ajnr.A0748","volume":"29","author":"JM de Souza","year":"2008","unstructured":"de Souza JM, Domingues RC, Cruz LC, Domingues FS, Iasbeck T, Gasparetto EL (2008) Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol 29:154\u2013158","journal-title":"AJNR Am J Neuroradiol"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/01.wnl.0000319659.86629.c8","volume":"71","author":"AD Cooper","year":"2008","unstructured":"Cooper AD, Campeau NG, Meissner I (2008) Susceptibility-weighted imaging in familial cerebral cavernous malformations. Neurology 71:382","journal-title":"Neurology"},{"key":"1_CR8","doi-asserted-by":"publisher","DOI":"10.3171\/2010.5.FOCUS10120","volume":"29","author":"PG Campbell","year":"2010","unstructured":"Campbell PG, Jabbour P, Yadla S, Awad IA (2010) Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus 29:E6","journal-title":"Neurosurg Focus"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3171\/2014.1.JNS131619","volume":"120","author":"SA Moore","year":"2014","unstructured":"Moore SA, Brown RD, Christianson TJ, Flemming KD (2014) Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg 120:1188\u20131192","journal-title":"J Neurosurg"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrneurol.2009.177","volume":"5","author":"S Batra","year":"2009","unstructured":"Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D (2009) Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 5:659\u2013670","journal-title":"Nat Rev Neurol"},{"key":"1_CR11","first-page":"201","volume":"59","author":"E Trapani","year":"2015","unstructured":"Trapani E, Retta SF (2015) Cerebral cavernous malformation (CCM) disease: from monogenic forms to genetic susceptibility factors. J Neurosurg Sci 59:201\u2013209","journal-title":"J Neurosurg Sci"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.biocel.2016.09.011","volume":"81","author":"SF Retta","year":"2016","unstructured":"Retta SF, Glading AJ (2016) Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin. Int J Biochem Cell Biol 81:254\u2013270","journal-title":"Int J Biochem Cell Biol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3171\/2011.8.JNS101241","volume":"116","author":"DD Cavalcanti","year":"2012","unstructured":"Cavalcanti DD, Kalani MY, Martirosyan NL, Eales J, Spetzler RF, Preul MC (2012) Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg 116:122\u2013132","journal-title":"J Neurosurg"},{"key":"1_CR14","first-page":"211","volume":"59","author":"H Choquet","year":"2015","unstructured":"Choquet H, Pawlikowska L, Lawton MT, Kim H (2015) Genetics of cerebral cavernous malformations: current status and future prospects. J Neurosurg Sci 59:211\u2013220","journal-title":"J Neurosurg Sci"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1161\/STROKEAHA.118.022314","volume":"50","author":"A Zafar","year":"2019","unstructured":"Zafar A, Quadri SA, Farooqui M, Ikram A, Robinson M, Hart BL, Mabray MC, Vigil C, Tang AT, Kahn ML, Yonas H, Lawton MT, Kim H, Morrison L (2019) Familial cerebral cavernous malformations. Stroke 50:1294\u20131301","journal-title":"Stroke"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3174\/ajnr.A1822","volume":"31","author":"TA Petersen","year":"2010","unstructured":"Petersen TA, Morrison LA, Schrader RM, Hart BL (2010) Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. AJNR Am J Neuroradiol 31:377\u2013382","journal-title":"AJNR Am J Neuroradiol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2377-14-50","volume":"14","author":"G Meng","year":"2014","unstructured":"Meng G, Bai C, Yu T, Wu Z, Liu X, Zhang J, Zhao J (2014) The association between cerebral developmental venous anomaly and concomitant cavernous malformation: an observational study using magnetic resonance imaging. BMC Neurol 14:50","journal-title":"BMC Neurol"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00381-017-3484-0","volume":"33","author":"W Brinjikji","year":"2017","unstructured":"Brinjikji W, El-Masri AE, Wald JT, Flemming KD, Lanzino G (2017) Prevalence of cerebral cavernous malformations associated with developmental venous anomalies increases with age. Childs Nerv Syst 33:1539\u20131543","journal-title":"Childs Nerv Syst"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N, Girard R, Zeineddine HA, Lightle R, Moore T, Cao Y, Shenkar R, Chen M, Mericko P, Yang J, Li L, Tanes C, Kobuley D, V\u00f5sa U, Whitehead KJ, Li DY, Franke L, Hart B, Schwaninger M, Henao-Mejia J, Morrison L, Kim H, Awad IA, Zheng X, Kahn ML (2017) Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545:305\u2013310","journal-title":"Nature"},{"key":"1_CR20","first-page":"1046","volume":"55","author":"MM Fontanella","year":"2015","unstructured":"Fontanella MM, Panciani PP, Spena G, Roca E, Migliorati K, Ambrosi C, Sturiale CL, Retta SF (2015) Professional athletes and cerebral cavernomas: an obstacle to overcome. J Sports Med Phys Fitness 55:1046\u20131047","journal-title":"J Sports Med Phys Fitness"},{"key":"1_CR21","first-page":"199","volume":"59","author":"M Fontanella","year":"2015","unstructured":"Fontanella M, Bacigaluppi S (2015) Treatment of cerebral cavernous malformations: where do we stand? J Neurosurg Sci 59:199\u2013200","journal-title":"J Neurosurg Sci"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.3.JNS181724","volume":"131","author":"IA Awad","year":"2019","unstructured":"Awad IA, Polster SP (2019) Cavernous angiomas: deconstructing a neurosurgical disease. J Neurosurg 131:1\u201313","journal-title":"J Neurosurg"},{"key":"1_CR23","doi-asserted-by":"crossref","unstructured":"Mabray MC, Caprihan A, Nelson J, McCulloch CE, Zafar A, Kim H, Hart BL, Morrison L (2019) Effect of simvastatin on permeability in cerebral cavernous malformation type 1 patients: results from a pilot small randomized controlled clinical trial. Transl Stroke Res","DOI":"10.1007\/s12975-019-00737-4"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/hmg\/8.12.2325","volume":"8","author":"T Sahoo","year":"1999","unstructured":"Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B, Kurth JH, Louis DN, Mettler G, Morrison L, Gil-Nagel A, Rich SS, Zabramski JM, Boguski MS, Green ED, Marchuk DA (1999) Mutations in the gene encoding KRIT1, a Krev-1\/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8:2325\u20132333","journal-title":"Hum Mol Genet"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/13815","volume":"23","author":"S Laberge-le Couteulx","year":"1999","unstructured":"Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E (1999) Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189\u2013193","journal-title":"Nat Genet"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/sj.onc.1201268","volume":"15","author":"I Serebriiskii","year":"1997","unstructured":"Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA (1997) Association of Krev-1\/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15:1043\u20131049","journal-title":"Oncogene"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1242\/jcs.02584","volume":"118","author":"F Balzac","year":"2005","unstructured":"Balzac F, Avolio M, Degani S, Kaverina I, Torti M, Silengo L, Small JV, Retta SF (2005) E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function. J Cell Sci 118:4765\u20134783","journal-title":"J Cell Sci"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejcb.2005.09.007","volume":"85","author":"SF Retta","year":"2006","unstructured":"Retta SF, Balzac F, Avolio M (2006) Rap1: a turnabout for the crosstalk between cadherins and integrins. Eur J Cell Biol 85:283\u2013293","journal-title":"Eur J Cell Biol"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-62703-791-4_13","volume":"1120","author":"L Goitre","year":"2014","unstructured":"Goitre L, Cutano V, Retta SF (2014) Fluorescence microscopy study of Rap1 subcellular localization. Methods Mol Biol 1120:197\u2013205","journal-title":"Methods Mol Biol"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-62703-791-4_12","volume":"1120","author":"L Goitre","year":"2014","unstructured":"Goitre L, Retta SF (2014) Combined pulldown and time-lapse microscopy studies for determining the role of Rap1 in the crosstalk between integrins and cadherins. Methods Mol Biol 1120:177\u2013195","journal-title":"Methods Mol Biol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/380314","volume":"73","author":"CL Liquori","year":"2003","unstructured":"Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA, Ptacek L, Marchuk DA (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459\u20131464","journal-title":"Am J Hum Genet"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1086\/381718","volume":"74","author":"C Denier","year":"2004","unstructured":"Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, Comoy J, Frerebeau P, Gilbert B, Houtteville JP, Jan M, Lapierre F, Loiseau H, Menei P, Mercier P, Moreau JJ, Nivelon-Chevallier A, Parker F, Redondo AM, Scarabin JM, Tremoulet M, Zerah M, Maciazek J, Tournier-Lasserve E, S. F. d. Neurochirurgie (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74:326\u2013337","journal-title":"Am J Hum Genet"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","volume":"76","author":"F Bergametti","year":"2005","unstructured":"Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E, S. F. d. Neurochirurgie (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76:42\u201351","journal-title":"Am J Hum Genet"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.20947","volume":"60","author":"C Denier","year":"2006","unstructured":"Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Arnoult M, Maciazek J, Vicaut E, Brunereau L, Tournier-Lasserve E, S. F. d. Neurochirurgie (2006) Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 60:550\u2013556","journal-title":"Ann Neurol"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1750-3639.2010.00441.x","volume":"21","author":"R D\u2019Angelo","year":"2011","unstructured":"D\u2019Angelo R, Marini V, Rinaldi C, Origone P, Dorcaratto A, Avolio M, Goitre L, Forni M, Capra V, Alafaci C, Mareni C, Garr\u00e8 C, Bramanti P, Sidoti A, Retta SF, Amato A (2011) Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation. Brain Pathol 21:215\u2013224","journal-title":"Brain Pathol"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000486292","volume":"9","author":"S Spiegler","year":"2018","unstructured":"Spiegler S, Rath M, Paperlein C, Felbor U (2018) Cerebral cavernous malformations: an update on prevalence, molecular genetic analyses, and genetic counselling. Mol Syndromol 9:60\u201369","journal-title":"Mol Syndromol"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1742-4658.2009.07535.x","volume":"277","author":"F Riant","year":"2010","unstructured":"Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E (2010) Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J 277:1070\u20131075","journal-title":"FEBS J"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000356839","volume":"37","author":"H Choquet","year":"2014","unstructured":"Choquet H, Nelson J, Pawlikowska L, McCulloch CE, Akers A, Baca B, Khan Y, Hart B, Morrison L, Kim H (2014) Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. Cerebrovasc Dis 37:57\u201363","journal-title":"Cerebrovasc Dis"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000369200","volume":"38","author":"H Choquet","year":"2014","unstructured":"Choquet H, Pawlikowska L, Nelson J, McCulloch CE, Akers A, Baca B, Khan Y, Hart B, Morrison L, Kim H, B. V. M. C. B. Study (2014) Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity. Cerebrovasc Dis 38:433\u2013440","journal-title":"Cerebrovasc Dis"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2016.01.008","volume":"92","author":"H Choquet","year":"2016","unstructured":"Choquet H, Trapani E, Goitre L, Trabalzini L, Akers A, Fontanella M, Hart BL, Morrison LA, Pawlikowska L, Kim H, Retta SF (2016) Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in cerebral cavernous malformation type 1. Free Radic Biol Med 92:100\u2013109","journal-title":"Free Radic Biol Med"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.yexcr.2008.10.006","volume":"315","author":"F Francalanci","year":"2009","unstructured":"Francalanci F, Avolio M, De Luca E, Longo D, Menchise V, Guazzi P, Sgr\u00f2 F, Marino M, Goitre L, Balzac F, Trabalzini L, Retta SF (2009) Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp Cell Res 315:285\u2013303","journal-title":"Exp Cell Res"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1083\/jcb.201205109","volume":"199","author":"AR Gingras","year":"2012","unstructured":"Gingras AR, Liu JJ, Ginsberg MH (2012) Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. J Cell Biol 199:39\u201348","journal-title":"J Cell Biol"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"22317","DOI":"10.1074\/jbc.M112.361295","volume":"287","author":"X Li","year":"2012","unstructured":"Li X, Zhang R, Draheim KM, Liu W, Calderwood DA, Boggon TJ (2012) Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1). J Biol Chem 287:22317\u201322327","journal-title":"J Biol Chem"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.gene.2003.09.046","volume":"325","author":"SF Retta","year":"2004","unstructured":"Retta SF, Avolio M, Francalanci F, Procida S, Balzac F, Degani S, Tarone G, Silengo L (2004) Identification of Krit1B: a novel alternative splicing isoform of cerebral cavernous malformation gene-1. Gene 325:63\u201378","journal-title":"Gene"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1242\/jcs.138388","volume":"127","author":"KM Draheim","year":"2014","unstructured":"Draheim KM, Fisher OS, Boggon TJ, Calderwood DA (2014) Cerebral cavernous malformation proteins at a glance. J Cell Sci 127:701\u2013707","journal-title":"J Cell Sci"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00018-013-1532-9","volume":"71","author":"OS Fisher","year":"2014","unstructured":"Fisher OS, Boggon TJ (2014) Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell Mol Life Sci 71:1881\u20131892","journal-title":"Cell Mol Life Sci"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1083\/jcb.201407129","volume":"208","author":"KM Draheim","year":"2015","unstructured":"Draheim KM, Li X, Zhang R, Fisher OS, Villari G, Boggon TJ, Calderwood DA (2015) CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation. J Cell Biol 208:987\u20131001","journal-title":"J Cell Biol"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"7937","DOI":"10.1038\/ncomms8937","volume":"6","author":"OS Fisher","year":"2015","unstructured":"Fisher OS, Deng H, Liu D, Zhang Y, Wei R, Deng Y, Zhang F, Louvi A, Turk BE, Boggon TJ, Su B (2015) Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex. Nat Commun 6:7937","journal-title":"Nat Commun"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1242\/jcs.061341","volume":"123","author":"M Fidalgo","year":"2010","unstructured":"Fidalgo M, Fraile M, Pires A, Force T, Pombo C, Zalvide J (2010) CCM3\/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation. J Cell Sci 123:1274\u20131284","journal-title":"J Cell Sci"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ydbio.2011.12.006","volume":"362","author":"B Yoruk","year":"2012","unstructured":"Yoruk B, Gillers BS, Chi NC, Scott IC (2012) Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease. Dev Biol 362:121\u2013131","journal-title":"Dev Biol"},{"key":"1_CR51","first-page":"1265","volume":"28","author":"J Zalvide","year":"2013","unstructured":"Zalvide J, Fidalgo M, Fraile M, Guerrero A, Iglesias C, Floridia E, Pombo CM (2013) The CCM3-GCKIII partnership. Histol Histopathol 28:1265\u20131272","journal-title":"Histol Histopathol"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.str.2013.02.015","volume":"21","author":"M Zhang","year":"2013","unstructured":"Zhang M, Dong L, Shi Z, Jiao S, Zhang Z, Zhang W, Liu G, Chen C, Feng M, Hao Q, Wang W, Yin M, Zhao Y, Zhang L, Zhou Z (2013) Structural mechanism of CCM3 heterodimerization with GCKIII kinases. Structure 21:680\u2013688","journal-title":"Structure"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10048-007-0098-9","volume":"8","author":"K Voss","year":"2007","unstructured":"Voss K, Stahl S, Schleider E, Ullrich S, Nickel J, Mueller TD, Felbor U (2007) CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 8:249\u2013256","journal-title":"Neurogenetics"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1038\/ncomms7449","volume":"6","author":"B Lant","year":"2015","unstructured":"Lant B, Yu B, Goudreault M, Holmyard D, Knight JD, Xu P, Zhao L, Chin K, Wallace E, Zhen M, Gingras AC, Derry WB (2015) CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling. Nat Commun 6:6449","journal-title":"Nat Commun"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cub.2017.02.028","volume":"27","author":"S Pal","year":"2017","unstructured":"Pal S, Lant B, Yu B, Tian R, Tong J, Krieger JR, Moran MF, Gingras AC, Derry WB (2017) CCM-3 promotes C. elegans germline development by regulating vesicle trafficking cytokinesis and polarity. Curr Biol 27:868\u2013876","journal-title":"Curr Biol"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1074\/mcp.M800266-MCP200","volume":"8","author":"M Goudreault","year":"2009","unstructured":"Goudreault M, D\u2019Ambrosio LM, Kean MJ, Mullin MJ, Larsen BG, Sanchez A, Chaudhry S, Chen GI, Sicheri F, Nesvizhskii AI, Aebersold R, Raught B, Gingras AC (2009) A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol Cell Proteomics 8:157\u2013171","journal-title":"Mol Cell Proteomics"},{"key":"1_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011786","volume":"5","author":"L Goitre","year":"2010","unstructured":"Goitre L, Balzac F, Degani S, Degan P, Marchi S, Pinton P, Retta SF (2010) KRIT1 regulates the homeostasis of intracellular reactive oxygen species. PLoS One 5:e11786","journal-title":"PLoS One"},{"key":"1_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044705","volume":"7","author":"P Guazzi","year":"2012","unstructured":"Guazzi P, Goitre L, Ferro E, Cutano V, Martino C, Trabalzini L, Retta SF (2012) Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1. PLoS One 7:e44705","journal-title":"PLoS One"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2013.11.020","volume":"68","author":"L Goitre","year":"2014","unstructured":"Goitre L, De Luca E, Braggion S, Trapani E, Guglielmotto M, Biasi F, Forni M, Moglia A, Trabalzini L, Retta SF (2014) KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun. Free Radic Biol Med 68:134\u2013147","journal-title":"Free Radic Biol Med"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.15252\/emmm.201505316","volume":"7","author":"S Marchi","year":"2015","unstructured":"Marchi S, Corricelli M, Trapani E, Bravi L, Pittaro A, Delle Monache S, Ferroni L, Patergnani S, Missiroli S, Goitre L, Trabalzini L, Rimessi A, Giorgi C, Zavan B, Cassoni P, Dejana E, Retta SF, Pinton P (2015) Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med 7:1403\u20131417","journal-title":"EMBO Mol Med"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","volume":"131","author":"CC Gibson","year":"2015","unstructured":"Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, Walker AE, Goitre L, Delle Monache S, Retta SF, Shiu YT, Grossmann AH, Thomas KR, Donato AJ, Lesniewski LA, Whitehead KJ, Li DY (2015) Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation. Circulation 131:289\u2013299","journal-title":"Circulation"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/biof.1197","volume":"41","author":"A Moglia","year":"2015","unstructured":"Moglia A, Goitre L, Gianoglio S, Baldini E, Trapani E, Genre A, Scattina A, Dondo G, Trabalzini L, Beekwilder J, Retta SF (2015) Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast. Biofactors 41:15\u201327","journal-title":"Biofactors"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1039\/C5NR08358C","volume":"8","author":"M Moglianetti","year":"2016","unstructured":"Moglianetti M, De Luca E, Pedone D, Marotta R, Catelani T, Sartori B, Amenitsch H, Retta SF, Pompa PP (2016) Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model. Nanoscale 8:3739\u20133752","journal-title":"Nanoscale"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.1038\/s41598-017-08373-4","volume":"7","author":"L Goitre","year":"2017","unstructured":"Goitre L, DiStefano PV, Moglia A, Nobiletti N, Baldini E, Trabalzini L, Keubel J, Trapani E, Shuvaev VV, Muzykantov VR, Sarelius IH, Retta SF, Glading AJ (2017) Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium. Sci Rep 7:8296","journal-title":"Sci Rep"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1084\/jem.20171178","volume":"214","author":"MA Lopez-Ramirez","year":"2017","unstructured":"Lopez-Ramirez MA, Fonseca G, Zeineddine HA, Girard R, Moore T, Pham A, Cao Y, Shenkar R, de Kreuk BJ, Lagarrigue F, Lawler J, Glass CK, Awad IA, Ginsberg MH (2017) Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J Exp Med 214:3331\u20133346","journal-title":"J Exp Med"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"15389","DOI":"10.1021\/acsomega.8b01653","volume":"3","author":"E De Luca","year":"2018","unstructured":"De Luca E, Pedone D, Moglianetti M, Pulcini D, Perrelli A, Retta SF, Pompa PP (2018) Multifunctional platinum@BSA-rapamycin nanocarriers for the combinatorial therapy of cerebral cavernous malformation. ACS Omega 3:15389\u201315398","journal-title":"ACS Omega"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2017.11.014","volume":"115","author":"C Antognelli","year":"2018","unstructured":"Antognelli C, Trapani E, Delle Monache S, Perrelli A, Daga M, Pizzimenti S, Barrera G, Cassoni P, Angelucci A, Trabalzini L, Talesa VN, Goitre L, Retta SF (2018) KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for cerebral cavernous malformation disease. Free Radic Biol Med 115:202\u2013218","journal-title":"Free Radic Biol Med"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.dib.2017.12.026","volume":"16","author":"C Antognelli","year":"2018","unstructured":"Antognelli C, Trapani E, Delle Monache S, Perrelli A, Fornelli C, Retta F, Cassoni P, Talesa VN, Retta SF (2018) Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function. Data Brief 16:929\u2013938","journal-title":"Data Brief"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.3390\/antiox8010027","volume":"8","author":"L Cianfruglia","year":"2019","unstructured":"Cianfruglia L, Perrelli A, Fornelli C, Magini A, Gorbi S, Salzano AM, Antognelli C, Retta F, Benedetti V, Cassoni P, Emiliani C, Principato G, Scaloni A, Armeni T, Retta SF (2019) KRIT1 loss-of-function associated with cerebral cavernous malformation disease leads to enhanced. Antioxidants (Basel) 8:E27","journal-title":"Antioxidants (Basel)"},{"key":"1_CR70","doi-asserted-by":"crossref","unstructured":"Vieceli Dalla Sega F, Mastrocola R, Aquila G, Fortini F, Fornelli C, Zotta A, Cento AS, Perrelli A, Boda E, Pannuti A, Marchi S, Pinton P, Ferrari R, Rizzo P, Retta SF (2019) KRIT1 deficiency promotes aortic endothelial dysfunction. Int J Mol Sci 20","DOI":"10.3390\/ijms20194930"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/j.1742-4658.2009.07536.x","volume":"277","author":"AC Chan","year":"2010","unstructured":"Chan AC, Li DY, Berg MJ, Whitehead KJ (2010) Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype. FEBS J 277:1076\u20131083","journal-title":"FEBS J"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1242\/dev.01036","volume":"131","author":"KJ Whitehead","year":"2004","unstructured":"Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY (2004) Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131:1437\u20131448","journal-title":"Development"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm.1911","volume":"15","author":"KJ Whitehead","year":"2009","unstructured":"Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY (2009) The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15:177\u2013184","journal-title":"Nat Med"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1242\/dmm.001263","volume":"2","author":"G Boulday","year":"2009","unstructured":"Boulday G, Bl\u00e9con A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M, Giovannini M, Tournier-Lasserve E (2009) Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis Model Mech 2:168\u2013177","journal-title":"Dis Model Mech"},{"key":"1_CR75","first-page":"ra26","volume":"3","author":"Y He","year":"2010","unstructured":"He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H, Min W (2010) Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Sig 3:ra26","journal-title":"Sci Sig"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature12207","volume":"498","author":"L Maddaluno","year":"2013","unstructured":"Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, Tournier-Lasserve E, Chapon F, Richichi C, Retta SF, Lampugnani MG, Dejana E (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498:492\u2013496","journal-title":"Nature"},{"key":"1_CR77","doi-asserted-by":"crossref","unstructured":"Choi JP, Yang X, Foley M, Wang X, Zheng X (2017) Induction and micro-CT imaging of cerebral cavernous malformations in mouse model. J Vis Exp","DOI":"10.3791\/56476"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1172\/JCI39679","volume":"120","author":"X Zheng","year":"2010","unstructured":"Zheng X, Xu C, Di Lorenzo A, Kleaveland B, Zou Z, Seiler C, Chen M, Cheng L, Xiao J, He J, Pack MA, Sessa WC, Kahn ML (2010) CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 120:2795\u20132804","journal-title":"J Clin Invest"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.devcel.2014.12.016","volume":"32","author":"M Renz","year":"2015","unstructured":"Renz M, Otten C, Faurobert E, Rudolph F, Zhu Y, Boulday G, Duchene J, Mickoleit M, Dietrich AC, Ramspacher C, Steed E, Manet-Dup\u00e9 S, Benz A, Hassel D, Vermot J, Huisken J, Tournier-Lasserve E, Felbor U, Sure U, Albiges-Rizo C, Abdelilah-Seyfried S (2015) Regulation of \u03b21 integrin-Klf2-mediated angiogenesis by CCM proteins. Dev Cell 32:181\u2013190","journal-title":"Dev Cell"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"e9155","DOI":"10.15252\/emmm.201809155","volume":"10","author":"C Otten","year":"2018","unstructured":"Otten C, Knox J, Boulday G, Eymery M, Haniszewski M, Neuenschwander M, Radetzki S, Vogt I, H\u00e4hn K, De Luca C, Cardoso C, Hamad S, Igual Gil C, Roy P, Albiges-Rizo C, Faurobert E, von Kries JP, Campillos M, Tournier-Lasserve E, Derry WB, Abdelilah-Seyfried S (2018) Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Mol Med 10:e9155","journal-title":"EMBO Mol Med"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cub.2009.12.032","volume":"20","author":"S Ito","year":"2010","unstructured":"Ito S, Greiss S, Gartner A, Derry WB (2010) Cell-nonautonomous regulation of C. elegans germ cell death by kri-1. Curr Biol 20:333\u2013338","journal-title":"Curr Biol"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1038\/s41467-019-09829-z","volume":"10","author":"EM Chapman","year":"2019","unstructured":"Chapman EM, Lant B, Ohashi Y, Yu B, Schertzberg M, Go C, Dogra D, Koskim\u00e4ki J, Girard R, Li Y, Fraser AG, Awad IA, Abdelilah-Seyfried S, Gingras AC, Derry WB (2019) A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis. Nat Commun 10:1791","journal-title":"Nat Commun"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.devcel.2013.05.002","volume":"25","author":"Y Song","year":"2013","unstructured":"Song Y, Eng M, Ghabrial AS (2013) Focal defects in single-celled tubes mutant for Cerebral cavernous malformation 3, GCKIII, or NSF2. Dev Cell 25:507\u2013519","journal-title":"Dev Cell"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/01.STR.0000157586.20479.fd","volume":"36","author":"J Gault","year":"2005","unstructured":"Gault J, Shenkar R, Recksiek P, Awad IA (2005) Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36:872\u2013874","journal-title":"Stroke"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18:919\u2013930","journal-title":"Hum Mol Genet"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/hmg\/ddn420","volume":"18","author":"A Pagenstecher","year":"2009","unstructured":"Pagenstecher A, Stahl S, Sure U, Felbor U (2009) A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18:911\u2013918","journal-title":"Hum Mol Genet"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/hmg\/ddq433","volume":"20","author":"DA McDonald","year":"2011","unstructured":"McDonald DA, Shenkar R, Shi C, Stockton RA, Akers AL, Kucherlapati MH, Kucherlapati R, Brainer J, Ginsberg MH, Awad IA, Marchuk DA (2011) A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet 20:211\u2013222","journal-title":"Hum Mol Genet"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","volume":"23","author":"DA McDonald","year":"2014","unstructured":"McDonald DA, Shi C, Shenkar R, Gallione CJ, Akers AL, Li S, De Castro N, Berg MJ, Corcoran DL, Awad IA, Marchuk DA (2014) Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet 23:4357\u20134370","journal-title":"Hum Mol Genet"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.118.313970","volume":"123","author":"MR Detter","year":"2018","unstructured":"Detter MR, Snellings DA, Marchuk DA (2018) Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ Res 123:1143\u20131151","journal-title":"Circ Res"},{"issue":"3","key":"1_CR90","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/jmedgenet-2019-106182","volume":"57","author":"M Rath","year":"2020","unstructured":"Rath M, Pagenstecher A, Hoischen A, Felbor U (2020) Postzygotic mosaicism in cerebral cavernous malformation. J Med Genet 57(3):212\u2013216","journal-title":"J Med Genet"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1038\/s41467-019-10707-x","volume":"10","author":"M Malinverno","year":"2019","unstructured":"Malinverno M, Maderna C, Abu Taha A, Corada M, Orsenigo F, Valentino M, Pisati F, Fusco C, Graziano P, Giannotta M, Yu QC, Zeng YA, Lampugnani MG, Magnusson PU, Dejana E (2019) Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat Commun 10:2761","journal-title":"Nat Commun"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.20110571","volume":"208","author":"G Boulday","year":"2011","unstructured":"Boulday G, Rudini N, Maddaluno L, Bl\u00e9con A, Arnould M, Gaudric A, Chapon F, Adams RH, Dejana E, Tournier-Lasserve E (2011) Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J Exp Med 208:1835\u20131847","journal-title":"J Exp Med"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1172\/JCI44393","volume":"121","author":"AC Chan","year":"2011","unstructured":"Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li DY (2011) Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest 121:1871\u20131881","journal-title":"J Clin Invest"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature17178","volume":"532","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, Zhou S, Yang J, Wright AC, Foley M, Arthur JS, Whitehead KJ, Awad IA, Li DY, Zheng X, Kahn ML (2016) Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling. Nature 532:122\u2013126","journal-title":"Nature"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1073\/pnas.1012617108","volume":"108","author":"A Louvi","year":"2011","unstructured":"Louvi A, Chen L, Two AM, Zhang H, Min W, G\u00fcnel M (2011) Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc Natl Acad Sci U S A 108:3737\u20133742","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1399-0004.2012.01892.x","volume":"83","author":"S Bacigaluppi","year":"2013","unstructured":"Bacigaluppi S, Retta SF, Pileggi S, Fontanella M, Goitre L, Tassi L, La Camera A, Citterio A, Patrosso MC, Tredici G, Penco S (2013) Genetic and cellular basis of cerebral cavernous malformations: implications for clinical management. Clin Genet 83:7\u201314","journal-title":"Clin Genet"},{"key":"1_CR97","doi-asserted-by":"publisher","DOI":"10.1080\/21675511.2016.1142640","volume":"4","author":"S Marchi","year":"2016","unstructured":"Marchi S, Trapani E, Corricelli M, Goitre L, Pinton P, Retta SF (2016) Beyond multiple mechanisms and a unique drug: defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies. Rare Dis 4:e1142640","journal-title":"Rare Dis"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1083\/jcb.200705175","volume":"179","author":"A Glading","year":"2007","unstructured":"Glading A, Han J, Stockton RA, Ginsberg MH (2007) KRIT-1\/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179:247\u2013254","journal-title":"J Cell Biol"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1242\/dmm.003293","volume":"3","author":"AJ Glading","year":"2010","unstructured":"Glading AJ, Ginsberg MH (2010) Rap1 and its effector KRIT1\/CCM1 regulate beta-catenin signaling. Dis Model Mech 3:73\u201383","journal-title":"Dis Model Mech"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2012.12.005","volume":"49","author":"W Liu","year":"2013","unstructured":"Liu W, Draheim KM, Zhang R, Calderwood DA, Boggon TJ (2013) Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. Mol Cell 49:719\u2013729","journal-title":"Mol Cell"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1083\/jcb.201303044","volume":"202","author":"E Faurobert","year":"2013","unstructured":"Faurobert E, Rome C, Lisowska J, Manet-Dup\u00e9 S, Boulday G, Malbouyres M, Balland M, Bouin AP, K\u00e9ramidas M, Bouvard D, Coll JL, Ruggiero F, Tournier-Lasserve E, Albiges-Rizo C (2013) CCM1-ICAP-1 complex controls \u03b21 integrin-dependent endothelial contractility and fibronectin remodeling. J Cell Biol 202:545\u2013561","journal-title":"J Cell Biol"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1242\/bio.201410132","volume":"3","author":"Z Macek Jilkova","year":"2014","unstructured":"Macek Jilkova Z, Lisowska J, Manet S, Verdier C, Deplano V, Geindreau C, Faurobert E, Albig\u00e8s-Rizo C, Duperray A (2014) CCM proteins control endothelial \u03b21 integrin dependent response to shear stress. Biol Open 3:1228\u20131235","journal-title":"Biol Open"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"13301","DOI":"10.1074\/jbc.C900009200","volume":"284","author":"LE Crose","year":"2009","unstructured":"Crose LE, Hilder TL, Sciaky N, Johnson GL (2009) Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem 284:13301\u201313305","journal-title":"J Biol Chem"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1074\/jbc.C109.097220","volume":"285","author":"AL Borikova","year":"2010","unstructured":"Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, Johnson GL (2010) Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 285:11760\u201311764","journal-title":"J Biol Chem"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1084\/jem.20091258","volume":"207","author":"RA Stockton","year":"2010","unstructured":"Stockton RA, Shenkar R, Awad IA, Ginsberg MH (2010) Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207:881\u2013896","journal-title":"J Exp Med"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/hsz-2012-0243","volume":"394","author":"BT Richardson","year":"2013","unstructured":"Richardson BT, Dibble CF, Borikova AL, Johnson GL (2013) Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling. Biol Chem 394:35\u201342","journal-title":"Biol Chem"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"12640","DOI":"10.1073\/pnas.1000132107","volume":"107","author":"J W\u00fcstehube","year":"2010","unstructured":"W\u00fcstehube J, Bartol A, Liebler SS, Br\u00fctsch R, Zhu Y, Felbor U, Sure U, Augustin HG, Fischer A (2010) Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc Natl Acad Sci U S A 107:12640\u201312645","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/jcmm.12022","volume":"17","author":"C You","year":"2013","unstructured":"You C, Sandalcioglu IE, Dammann P, Felbor U, Sure U, Zhu Y (2013) Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. J Cell Mol Med 17:407\u2013418","journal-title":"J Cell Mol Med"},{"key":"1_CR109","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/STROKEAHA.114.007512","volume":"46","author":"GB Schulz","year":"2015","unstructured":"Schulz GB, Wieland E, W\u00fcstehube-Lausch J, Boulday G, Moll I, Tournier-Lasserve E, Fischer A (2015) Cerebral cavernous malformation-1 protein controls DLL4-Notch3 signaling between the endothelium and pericytes. Stroke 46:1337\u20131343","journal-title":"Stroke"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10143-015-0699-y","volume":"39","author":"S Kar","year":"2016","unstructured":"Kar S, Baisantry A, Nabavi A, Bertalanffy H (2016) Role of delta-notch signaling in cerebral cavernous malformations. Neurosurg Rev 39:581\u2013589","journal-title":"Neurosurg Rev"},{"key":"1_CR111","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/jcmm.13105","volume":"21","author":"C You","year":"2017","unstructured":"You C, Zhao K, Dammann P, Keyvani K, Kreitschmann-Andermahr I, Sure U, Zhu Y (2017) EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation. J Cell Mol Med 21:1848\u20131858","journal-title":"J Cell Mol Med"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"33054","DOI":"10.1074\/jbc.M114.582304","volume":"289","author":"PV DiStefano","year":"2014","unstructured":"DiStefano PV, Kuebel JM, Sarelius IH, Glading AJ (2014) KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling. J Biol Chem 289:33054\u201333065","journal-title":"J Biol Chem"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10143-014-0597-8","volume":"38","author":"S Kar","year":"2015","unstructured":"Kar S, Samii A, Bertalanffy H (2015) PTEN\/PI3K\/Akt\/VEGF signaling and the cross talk to KRIT1, CCM2, and PDCD10 proteins in cerebral cavernous malformations. Neurosurg Rev 38:229\u2013236; discussion 236\u2013227","journal-title":"Neurosurg Rev"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"14284","DOI":"10.1073\/pnas.1510495112","volume":"112","author":"X Cullere","year":"2015","unstructured":"Cullere X, Plovie E, Bennett PM, MacRae CA, Mayadas TN (2015) The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3. Proc Natl Acad Sci U S A 112:14284\u201314289","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","volume":"32","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Rawnsley DR, Goddard LM, Pan W, Cao XJ, Jakus Z, Zheng H, Yang J, Arthur JS, Whitehead KJ, Li D, Zhou B, Garcia BA, Zheng X, Kahn ML (2015) The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. Dev Cell 32:168\u2013180","journal-title":"Dev Cell"},{"key":"1_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160833","volume":"11","author":"JP Choi","year":"2016","unstructured":"Choi JP, Foley M, Zhou Z, Wong WY, Gokoolparsadh N, Arthur JS, Li DY, Zheng X (2016) Micro-CT imaging reveals Mekk3 heterozygosity prevents cerebral cavernous malformations in Ccm2-deficient mice. PLoS One 11:e0160833","journal-title":"PLoS One"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm.4169","volume":"22","author":"H Jenny Zhou","year":"2016","unstructured":"Jenny Zhou H, Qin L, Zhang H, Tang W, Ji W, He Y, Liang X, Wang Z, Yuan Q, Vortmeyer A, Toomre D, Fuh G, Yan M, Kluger MS, Wu D, Min W (2016) Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med 22:1033\u20131042","journal-title":"Nat Med"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15252\/emmm.201505433","volume":"8","author":"R Cuttano","year":"2016","unstructured":"Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E, Morini MF, Maddaluno L, Baeyens N, Adams RH, Jain MK, Owens GK, Schwartz M, Lampugnani MG, Dejana E (2016) KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med 8:6\u201324","journal-title":"EMBO Mol Med"},{"key":"1_CR119","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbrc.2013.07.031","volume":"438","author":"F Orso","year":"2013","unstructured":"Orso F, Balzac F, Marino M, Lembo A, Retta SF, Taverna D (2013) miR-21 coordinates tumor growth and modulates KRIT1 levels. Biochem Biophys Res Commun 438:90\u201396","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12031-017-0880-6","volume":"61","author":"S Kar","year":"2017","unstructured":"Kar S, Bali KK, Baisantry A, Geffers R, Samii A, Bertalanffy H (2017) Genome-wide sequencing reveals microRNAs downregulated in cerebral cavernous malformations. J Mol Neurosci 61:178\u2013188","journal-title":"J Mol Neurosci"},{"key":"1_CR121","doi-asserted-by":"crossref","unstructured":"Antognelli C, Perrelli A, Armeni T, Talesa VN, Retta SF, (2020) Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations. Antioxidants 9 (2):124","DOI":"10.3390\/antiox9020124"},{"key":"1_CR122","doi-asserted-by":"crossref","unstructured":"Finetti F, Schiavo I, Ercoli J, Zotta A, Boda E, Retta SF, Trabalzini L, (2020) KRIT1 loss-mediated upregulation of NOX1 in stromal cells promotes paracrine pro-angiogenic responses. Cellular Signalling 68:109527","DOI":"10.1016\/j.cellsig.2020.109527"},{"key":"1_CR123","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/15548627.2015.1125073","volume":"12","author":"S Marchi","year":"2016","unstructured":"Marchi S, Retta SF, Pinton P (2016) Cellular processes underlying cerebral cavernous malformations: autophagy as another point of view. Autophagy 12:424\u2013425","journal-title":"Autophagy"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1161\/ATVBAHA.112.300115","volume":"32","author":"M Corr","year":"2012","unstructured":"Corr M, Lerman I, Keubel JM, Ronacher L, Misra R, Lund F, Sarelius IH, Glading AJ (2012) Decreased Krev interaction-trapped 1 expression leads to increased vascular permeability and modifies inflammatory responses in vivo. Arterioscler Thromb Vasc Biol 32:2702\u20132710","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"11556","DOI":"10.1074\/jbc.M111.320259","volume":"287","author":"M Fidalgo","year":"2012","unstructured":"Fidalgo M, Guerrero A, Fraile M, Iglesias C, Pombo CM, Zalvide J (2012) Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin\/radixin\/moesin by mammalian Ste20-4 to protect cells from oxidative stress. J Biol Chem 287:11556\u201311565","journal-title":"J Biol Chem"},{"key":"1_CR126","first-page":"807682","volume":"2012","author":"L Goitre","year":"2012","unstructured":"Goitre L, Pergolizzi B, Ferro E, Trabalzini L, Retta SF (2012) Molecular crosstalk between integrins and cadherins: do reactive oxygen species set the talk? J Sig Transduct 2012:807682","journal-title":"J Sig Transduct"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-62703-791-4_5","volume":"1120","author":"E Ferro","year":"2014","unstructured":"Ferro E, Goitre L, Baldini E, Retta SF, Trabalzini L (2014) Ras GTPases are both regulators and effectors of redox agents. Methods Mol Biol 1120:55\u201374","journal-title":"Methods Mol Biol"},{"key":"1_CR128","doi-asserted-by":"crossref","unstructured":"Castro M, Lavi\u00f1a B, Ando K, \u00c1lvarez-Aznar A, Abu Taha A, Brakebusch C, Dejana E, Betsholtz C, Gaengel K (2019) CDC42 Deletion Elicits Cerebral Vascular Malformations via Increased MEKK3-Dependent KLF4 Expression. Circulation Research 124(8):1240\u20131252","DOI":"10.1161\/CIRCRESAHA.118.314300"},{"key":"1_CR129","unstructured":"Aaron Hobbs G, Zhou B, Cox AD, Campbell SL (2014) Rho GTPases, oxidation, and cell redox control. Small GTPases 5(2):e28579"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1161\/STROKEAHA.110.594929","volume":"41","author":"DY Li","year":"2010","unstructured":"Li DY, Whitehead KJ (2010) Evaluating strategies for the treatment of cerebral cavernous malformations. Stroke 41:S92\u2013S94","journal-title":"Stroke"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1073\/pnas.1702942114","volume":"114","author":"S Nishimura","year":"2017","unstructured":"Nishimura S, Mishra-Gorur K, Park J, Surovtseva YV, Sebti SM, Levchenko A, Louvi A, Gunel M (2017) Combined HMG-COA reductase and prenylation inhibition in treatment of CCM. Proc Natl Acad Sci U S A 114:5503\u20135508","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR132","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1161\/STROKEAHA.118.024058","volume":"50","author":"R Shenkar","year":"2019","unstructured":"Shenkar R, Peiper A, Pardo H, Moore T, Lightle R, Girard R, Hobson N, Polster SP, Koskim\u00e4ki J, Zhang D, Lyne SB, Cao Y, Chaudagar K, Saadat L, Gallione C, Pytel P, Liao JK, Marchuk D, Awad IA (2019) Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease. Stroke 50:738\u2013744","journal-title":"Stroke"},{"key":"1_CR133","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/STROKEAHA.111.625467","volume":"43","author":"DA McDonald","year":"2012","unstructured":"McDonald DA, Shi C, Shenkar R, Stockton RA, Liu F, Ginsberg MH, Marchuk DA, Awad IA (2012) Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 43:571\u2013574","journal-title":"Stroke"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/STROKEAHA.116.015013","volume":"48","author":"R Shenkar","year":"2017","unstructured":"Shenkar R, Shi C, Austin C, Moore T, Lightle R, Cao Y, Zhang L, Wu M, Zeineddine HA, Girard R, McDonald DA, Rorrer A, Gallione C, Pytel P, Liao JK, Marchuk DA, Awad IA (2017) RhoA kinase inhibition with fasudil versus simvastatin in murine models of cerebral cavernous malformations. Stroke 48:187\u2013194","journal-title":"Stroke"},{"key":"1_CR135","doi-asserted-by":"crossref","unstructured":"McKerracher L, Shenkar R, Abbinanti M, Cao Y, Peiper A, Liao JK, Lightle R, Moore T, Hobson N, Gallione C, Ruschel J, Koskim\u00e4ki J, Girard R, Rosen K, Marchuk DA, Awad IA (2019) A brain-targeted orally available ROCK2 inhibitor benefits mild and aggressive cavernous angioma disease. Transl Stroke Res","DOI":"10.1007\/s12975-019-00725-8"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1073\/pnas.1501352112","volume":"112","author":"L Bravi","year":"2015","unstructured":"Bravi L, Rudini N, Cuttano R, Giampietro C, Maddaluno L, Ferrarini L, Adams RH, Corada M, Boulday G, Tournier-Lasserve E, Dejana E, Lampugnani MG (2015) Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci U S A 112:8421\u20138426","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR137","doi-asserted-by":"publisher","first-page":"eaau0731","DOI":"10.1126\/sciadv.aau0731","volume":"4","author":"JP Choi","year":"2018","unstructured":"Choi JP, Wang R, Yang X, Wang X, Wang L, Ting KK, Foley M, Cogger V, Yang Z, Liu F, Han Z, Liu R, Baell J, Zheng X (2018) Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations. Sci Adv 4:eaau0731","journal-title":"Sci Adv"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi C, Shenkar R, Zeineddine HA, Girard R, Fam MD, Austin C, Moore T, Lightle R, Zhang L, Wu M, Cao Y, Gunel M, Louvi A, Rorrer A, Gallione C, Marchuk DA, Awad IA (2016) B-cell depletion reduces the maturation of cerebral cavernous malformations in murine models. J Neuroimmune Pharmacol 11:369\u2013377","journal-title":"J Neuroimmune Pharmacol"},{"key":"1_CR139","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1182\/blood-2018-06-856062","volume":"133","author":"MA Lopez-Ramirez","year":"2019","unstructured":"Lopez-Ramirez MA, Pham A, Girard R, Wyseure T, Hale P, Yamashita A, Koskim\u00e4ki J, Polster S, Saadat L, Romero IA, Esmon CT, Lagarrigue F, Awad IA, Mosnier LO, Ginsberg MH (2019) Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice. Blood 133:193\u2013204","journal-title":"Blood"},{"key":"1_CR140","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/0883073810363917","volume":"25","author":"M Moschovi","year":"2010","unstructured":"Moschovi M, Alexiou GA, Stefanaki K, Tourkantoni N, Prodromou N (2010) Propranolol treatment for a giant infantile brain cavernoma. J Child Neurol 25:653\u2013655","journal-title":"J Child Neurol"},{"key":"1_CR141","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.606251","volume":"42","author":"AS Filippidis","year":"2011","unstructured":"Filippidis AS, Fountas KN, Kalani MY, Zabramski JM, Spetzler RF (2011) Letter by Filippidis et al regarding article, \u201cEvaluating strategies for the treatment of cerebral cavernous malformations\u201d. Stroke 42:e373","journal-title":"Stroke"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/0009922813492885","volume":"53","author":"I Berti","year":"2014","unstructured":"Berti I, Marchetti F, Skabar A, Zennaro F, Zanon D, Ventura A (2014) Propranolol for cerebral cavernous angiomatosis: a magic bullet. Clin Pediatr (Phila) 53:189\u2013190","journal-title":"Clin Pediatr (Phila)"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.wneu.2015.11.003","volume":"88","author":"JM Zabramski","year":"2016","unstructured":"Zabramski JM, Kalani MYS, Filippidis AS, Spetzler RF (2016) Propranolol treatment of cavernous malformations with symptomatic hemorrhage. World Neurosurg 88:631\u2013639","journal-title":"World Neurosurg"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2016.04.053","volume":"367","author":"M Reinhard","year":"2016","unstructured":"Reinhard M, Schuchardt F, Meckel S, Heinz J, Felbor U, Sure U, Geisen U (2016) Propranolol stops progressive multiple cerebral cavernoma in an adult patient. J Neurol Sci 367:15\u201317","journal-title":"J Neurol Sci"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1161\/STROKEAHA.114.005132","volume":"45","author":"S Eisa-Beygi","year":"2014","unstructured":"Eisa-Beygi S, Wen XY, Macdonald RL (2014) A call for rigorous study of statins in resolution of cerebral cavernous malformation pathology. Stroke 45:1859\u20131861","journal-title":"Stroke"},{"key":"1_CR146","doi-asserted-by":"crossref","unstructured":"Goldberg J, Jaeggi C, Schoeni D, Mordasini P, Raabe A, Bervini D (2018) Bleeding risk of cerebral cavernous malformations in patients on \u03b2-blocker medication: a cohort study. J Neurosurg:1\u20136","DOI":"10.1055\/s-0038-1660732"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10143-018-01074-0","volume":"42","author":"C Apra","year":"2019","unstructured":"Apra C, Dumot C, Bourdillon P, Pelissou-Guyotat I (2019) Could propranolol be beneficial in adult cerebral cavernous malformations? Neurosurg Rev 42:403\u2013408","journal-title":"Neurosurg Rev"},{"key":"1_CR148","doi-asserted-by":"crossref","unstructured":"Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskim\u00e4ki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad IA (2018) Atorvastatin treatment of cavernous angiomas with symptomatic hemorrhage exploratory proof of concept (AT CASH EPOC) trial. Neurosurgery","DOI":"10.1093\/neuros\/nyy539"},{"key":"1_CR149","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/archneurol.2010.356","volume":"68","author":"MB Westover","year":"2011","unstructured":"Westover MB, Bianchi MT, Eckman MH, Greenberg SM (2011) Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol 68:573\u2013579","journal-title":"Arch Neurol"},{"key":"1_CR150","first-page":"565","volume":"68","author":"LB Goldstein","year":"2011","unstructured":"Goldstein LB (2011) Statins after intracerebral hemorrhage: to treat or not to treat. Arch Neurol 68:565\u2013566","journal-title":"Arch Neurol"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"6015351","DOI":"10.1155\/2018\/6015351","volume":"2018","author":"A Perrelli","year":"2018","unstructured":"Perrelli A, Goitre L, Salzano AM, Moglia A, Scaloni A, Retta SF (2018) Biological activities, health benefits, and therapeutic properties of avenanthramides: from skin protection to prevention and treatment of cerebrovascular diseases. Oxidative Med Cell Longev 2018:6015351","journal-title":"Oxidative Med Cell Longev"}],"container-title":["Methods in Molecular Biology","Cerebral Cavernous Malformations (CCM)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0640-7_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T19:39:29Z","timestamp":1616182769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0640-7_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071606391","9781071606407"],"references-count":151,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0640-7_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"11 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}